QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Welcome Jacob Elskær Mollerup!
This week we are welcoming a new colleague to our Copenhagen office!
Jacob Elskær Mollerup holds an engineering degree in Quantitative Biology and Disease Modelling from DTU – Technical University of Denmark. Prior to starting at Quantify Research, Jacob worked as a data scientist at Statens Serum Institut, as part of the […]
The future of Nordic HTA body collaboration: FINOSE is now JNHB
On June 3rd, FINOSE officially re-launched as JNHB (Joint Nordic HTA-Bodies).
Except for the name, news include a brand new web-page where information and supporting documents are available, and the inclusion of Iceland in the collaboration, through Landspitali University Hospital.
At the launch meeting it was made clear that the aim of JNHB is to increase transparency […]
Welcome Ville!
We are excited to welcome Ville Perälä, who is joining Quantify Research this week as Country Manager in Finland.
Ville has been working in pharmaceutical business, both as a consultant and in pharma companies, for almost a decade. He has experience from multiple areas, primarily focused on Medical Affairs, Real World Evidence and Market Access strategies in Nordic and Global positions.
“I am super happy […]
Are you or any of your colleagues attending EASL in Milan this week? Quantify is on site and happy to connect!
Two Quantify abstracts have been selected for poster presentation and for oral presentation in the Abstract session – “MASLD: Clinical aspects”.
The presentations include the first results from the REVEAL-MASH study conducted by Quantify’s Emilie Toresson Grip and Helena Skröder Löveborn in ongoing collaboration with Karolinska Institutet and Novo Nordisk. Emilie Toresson Grip will present the findings at […]